Hypothesis

Transient expression of Yamanaka factors (Oct4, Sox2, Klf4, c-Myc) in aged neurons reduces perineuronal net (PNN) density by inducing autophagy-dependent TET activity, which demethylates promoters of extracellular-matrix proteases (e.g., Plasmin, MMP-9) and thereby restores synaptic plasticity without triggering tumorigenic reprogramming.

Mechanistic Rationale

1. Yamanaka factors activate autophagy – transient OCT4/SOX2 upregulates lysosomal genes, increasing autophagic flux that fuels TET-mediated DNA demethylation via α-ketoglutarate supply, linking autophagy to epigenetic remodeling.
2. TET-driven demethylation targets protease genes – hypomethylation of promoters for PLAU (plasminogen activator) and MMP9 enhances their transcription, boosting enzymatic cleavage of PNN components such as aggrecan and link protein.
3. PNN degradation reopens plasticity windows – reduced PNN density permits LTP recovery and spine remodeling, particularly in hippocampal CA2 where age-related PNN accumulation is pronounced.
4. Region-specific outcome – striatal neurons, which maintain PNN homeostasis, show minimal change, predicting a dissociation between hippocampal and striatal plasticity outcomes.

Testable Predictions

• Prediction 1: In aged mice, a 4‑day doxycycline‑inducible Oct4/Sox2/Klf4/c-Myc pulse will increase LC3‑II/I ratio and autophagic flux in hippocampal neurons within 24 h (measureable by western blot or tandem fluorescent LC3 reporter).
• Prediction 2: The same pulse will elevate nuclear TET1/2 activity and reduce 5‑methylcytosine levels at the PlaU and Mmp9 promoters (assessed by bisulfite sequencing).
• Prediction 3: PNN staining (WFA lectin) will decrease by ~30 % in hippocampal CA2 after treatment, with no significant change in the dorsal striatum.
• Prediction 4: Electrophysiological LTP in hippocampal slices will be rescued to young‑adult levels, while striatal LTP remains unchanged.
• Prediction 5: Blocking autophagy (with chloroquine) or TET activity (with Bobcat339) during the Yamanaka pulse will prevent PNN reduction and plasticity rescue, confirming the autophagy‑TET‑protease axis.

Experimental Design (outline)

• Use CamKIIa-rtTA; TetO-OSKM mice aged 18‑20 months.
• Administer doxycycline for 96 h, then harvest tissue at 0, 24, 48, 72 h post‑induction for autophagy, TET, and PNN assays.
• Include control groups: vehicle‑induced aged mice, young (3‑month) mice, and aged mice treated with chondroitinase ABC (positive PNN degradation control).
• Behavioral readout: spatial pattern separation task sensitive to CA2 function; expect improvement only in Yamanaka‑treated aged mice.

Falsifiability

If transient Yamanaka factor expression fails to increase autophagic flux, does not alter TET activity or promoter methylation, and leaves PNN density and LTP unchanged, the hypothesis is refuted. Conversely, if PNN reduction occurs without autophagy/TET involvement, the proposed mechanistic chain would need revision.

Supporting Evidence from Prior Work

• PNNs increase with age across hippocampus, inferior colliculus and cortex, restricting synaptic plasticity and contributing to cognitive decline while offering neuroprotection against oxidative stress Perineuronal nets increase with agePNNs restrict synaptic plasticity and contribute to cognitive declinePNNs are neuroprotective against oxidative stress.
• Enzymatic degradation of PNNs rescues CA2 plasticity in mouse models, demonstrating that rigidity is reversible without addressing classical neurodegeneration Enzymatic PNN degradation rescues CA2 plasticity.
• Aged brains show epigenetic inflexibility with downregulation of synaptic plasticity genes and upregulation of immune/microglial genes Aged brains show epigenetic inflexibility with downregulation of synaptic plasticity genes and upregulation of immune/microglial genes.
• Hippocampus exhibits PNN accumulation with inflammation during aging, whereas the striatum maintains PNN homeostasis, highlighting region‑specific consolidation patterns Hippocampus shows PNN accumulation with inflammation during aging, while striatum maintains PNN homeostasis.
• General rejuvenation interventions reduce pro‑aging factors that impair neurogenesis General rejuvenation interventions reduce pro‑aging factors that impair neurogenesis, and brain aging biomarkers that track resilience are distinct from classical pathology markers Brain aging biomarkers that track resilience are distinct from classical pathology markers.